CVS Health is a healthcare plans business based in the US. CVS Health shares (CVS) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $64.59 – an increase of 5.23% over the previous week. CVS Health employs 219,000 staff and has a trailing 12-month revenue of around $361.9 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $64.59 |
|---|---|
| 52-week range | $52.18 - $80.80 |
| 50-day moving average | $58.38 |
| 200-day moving average | $66.23 |
| Wall St. target price | $64.97 |
| PE ratio | 10.9502 |
| Dividend yield | $2.54 (4.32%) |
| Earnings per share (TTM) | $5.62 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $64.59 from 2024-10-04
| 1 week (2024-09-27) | 5.23% |
|---|---|
| 1 month (2024-09-06) | 11.84% |
| 3 months (2024-07-05) | 14.08% |
| 6 months (2024-04-05) | -13.40% |
| 1 year (2023-10-06) | -7.60% |
|---|---|
| 2 years (2022-10-06) | -34.48% |
| 3 years (2021-10-06) | 83.15 |
| 5 years (2019-10-04) | 9.98% |
Valuing CVS Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CVS Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CVS Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, CVS Health shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
CVS Health's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.974. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CVS Health's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CVS Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $16.1 billion.
The EBITDA is a measure of a CVS Health's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $361.9 billion |
|---|---|
| Operating margin TTM | 3.03% |
| Gross profit TTM | $53.5 billion |
| Return on assets TTM | 2.87% |
| Return on equity TTM | 9.73% |
| Profit margin | 1.99% |
| Book value | $59.66 |
| Market Capitalization | $77.4 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like CVS Health.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 18.73
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and CVS Health's overall score of 18.73 (as at 12/31/2018) is excellent – landing it in it in the 19th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like CVS Health is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 1.92/100
Social score: 9.06/100
Governance score: 2.75/100
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. CVS Health scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that CVS Health hasn't always managed to keep its nose clean.
CVS Health Corp was last rated for ESG on: 2019-01-01.
| Total ESG score | 18.73 |
|---|---|
| Total ESG percentile | 18.84 |
| Environmental score | 1.92 |
| Social score | 9.06 |
| Governance score | 2.75 |
| Level of controversy | 3 |
Dividend payout ratio: 35.61% of net profits
Recently CVS Health has paid out, on average, around 35.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.32% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), CVS Health shareholders could enjoy a 4.32% return on their shares, in the form of dividend payments. In CVS Health's case, that would currently equate to about $2.54 per share.
While CVS Health's payout ratio might seem fairly standard, it's worth remembering that CVS Health may be investing much of the rest of its net profits in future growth.
CVS Health's most recent dividend payout was on 31 October 2024. The latest dividend was paid out to all shareholders who bought their shares by 20 October 2024 (the "ex-dividend date").
CVS Health's shares were split on a 2:1 basis on 6 June 2005. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your CVS Health shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for CVS Health shares which in turn could have impacted CVS Health's share price.
Over the last 12 months, CVS Health's shares have ranged in value from as little as $52.1814 up to $80.7979. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CVS Health's is 0.528. This would suggest that CVS Health's shares are less volatile than average (for this exchange).
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products.
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Check out the best-performing ETFs so far in 2024.